LFCR Logo

Lifecore Biomedical, Inc. (LFCR) 

NASDAQ$6.47
Market Cap
$239.55M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
54 of 924
Rank in Industry
2 of 56

LFCR Insider Trading Activity

LFCR Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$7,297,5783100
Sells
$000

Related Transactions

Kiper Christopher S1$6M0$0$6M
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I10 percent owner1$1.2M0$0$1.2M
Josephs PaulChief Executive Officer1$97,5800$0$97,580

About Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology â€¦

Insider Activity of Lifecore Biomedical, Inc.

Over the last 12 months, insiders at Lifecore Biomedical, Inc. have bought $7.3M and sold $0 worth of Lifecore Biomedical, Inc. stock.

On average, over the past 5 years, insiders at Lifecore Biomedical, Inc. have bought $6.15M and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Kiper Christopher S () — $6M. WYNNEFIELD PARTNERS SMALL CAP VALUE LP I (10 percent owner) — $1.2M. Josephs Paul (Chief Executive Officer) — $97,580.

The last purchase of 17,000 shares for transaction amount of $97,580 was made by Josephs Paul (Chief Executive Officer) on 2025‑01‑08.

List of Insider Buy and Sell Transactions, Lifecore Biomedical, Inc.

2025-01-08PurchaseJosephs PaulChief Executive Officer
17,000
0.0456%
$5.74$97,580+4.05%
2024-10-03PurchaseKiper Christopher S
1.46M
2.1987%
$4.10$6M+31.16%
2024-10-03PurchaseWYNNEFIELD PARTNERS SMALL CAP VALUE LP I10 percent owner
292,683
0.4397%
$4.10$1.2M+31.16%
2022-11-25PurchaseWYNNEFIELD PARTNERS SMALL CAP VALUE LP Idirector
627,746
1.8334%
$7.97$5M-14.58%
Total: 4
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Kiper Christopher S
4084268
11.031%
$26.43M10
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I10 percent owner
2607433
7.0423%
$16.87M20<0.0001%
Josephs PaulChief Executive Officer
559717
1.5117%
$3.62M10
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$2,051,022
1591
-12.84%
$76.27M
$22,899,264
81
34.90%
$26.7M
$218,350,131
64
16.68%
$296.77M
$125,860,243
57
-4.48%
$54.94M
$129,489,279
57
26.09%
$635.41M

LFCR Institutional Investors: Active Positions

Increased Positions41+46.59%5M+26.18%
Decreased Positions37-42.05%1M-6.38%
New Positions12New806,992New
Sold Out Positions19Sold Out437,737Sold Out
Total Postitions92+4.55%25M+19.8%

LFCR Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Wynnefield Capital Inc$27,467.0012.71%4.7M-215,763-4.39%2024-12-31
Legion Partners Asset Management, Llc$25,882.0011.98%4.43M+1M+49.3%2024-12-31
Greenhaven Road Investment Management, L.P.$21,118.009.77%3.62M+1M+62.25%2024-12-31
325 Capital Llc$12,629.005.85%2.16M+792,681+57.87%2024-12-31
22Nw, Lp$10,250.004.74%1.76M00%2024-12-31
Blackrock, Inc.$9,440.004.37%1.62M+103,535+6.84%2024-12-31
Vanguard Group Inc$8,939.004.14%1.53M+215,437+16.38%2024-12-31
Morgan Stanley$4,352.002.01%745,185-31,505-4.06%2024-12-31
Geode Capital Management, Llc$4,005.001.85%685,746+88,061+14.73%2024-12-31
Invesco Ltd.$3,245.001.5%555,607+555,607New2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
2.67SellsBuysStrong BuyBuyHoldSellStrong SellLFCRHighAverageLowSeries 4